Skip to main content
Premium Trial:

Request an Annual Quote

New Products: CeGaT's NGS Dx Panels

Premium

The Center for Genomics and Transcriptomics in Tübingen, Germany has launched next-generation sequencing panels for the diagnosis of ataxia, hereditary spastic paraplegia, spinal muscular atrophy, choreatic movement disorders, and leukodystrophy/leukoencephalopathy.

It has also launched panels for inherited kidney diseases. The comprehensive panel covers 145 genes associated with both isolated and syndromic nephropathies. It can also be run as 21 different subpanels.

Additionally, CeGaT has revised its diagnostic panel for neurodegenerative diseases from 16 to 22 subpanels.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.